IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic pain

Neuropathic pain, a highly debilitating pain condition that commonly occurs after nerve damage, is a reflection of the aberrant excitability of dorsal horn neurons. This pathologically altered neurotransmission requires a communication with spinal microglia activated by nerve injury. However, how normal resting microglia become activated remains unknown. Here we show that in naive animals spinal microglia express a receptor for the cytokine IFN-γ (IFN-γR) in a cell-type-specific manner and that stimulating this receptor converts microglia into activated cells and produces a long-lasting pain hypersensitivity evoked by innocuous stimuli (tactile allodynia, a hallmark symptom of neuropathic pain). Conversely, ablating IFN-γR severely impairs nerve injury-evoked microglia activation and tactile allodynia without affecting microglia in the contralateral dorsal horn or basal pain sensitivity. We also find that IFN-γ-stimulated spinal microglia show up-regulation of Lyn tyrosine kinase and purinergic P2X4 receptor, crucial events for neuropathic pain, and genetic approaches provide evidence linking these events to IFN-γR-dependent microglial and behavioral alterations. These results suggest that IFN-γR is a key element in the molecular machinery through which resting spinal microglia transform into an activated state that drives neuropathic pain.

[1]  H. Tozaki-Saitoh,et al.  P2Y12 Receptors in Spinal Microglia Are Required for Neuropathic Pain after Peripheral Nerve Injury , 2008, The Journal of Neuroscience.

[2]  J. Ando,et al.  Fibronectin/integrin system is involved in P2X4 receptor upregulation in the spinal cord and neuropathic pain after nerve injury , 2008, Glia.

[3]  H. Schluesener,et al.  Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats , 2008, Neuroscience.

[4]  Yi Dai,et al.  P2Y12 Receptor Upregulation in Activated Microglia Is a Gateway of p38 Signaling and Neuropathic Pain , 2008, The Journal of Neuroscience.

[5]  Ji Zhang,et al.  Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain , 2008, PAIN®.

[6]  H. Tozaki-Saitoh,et al.  Lyn tyrosine kinase is required for P2X4 receptor upregulation and neuropathic pain after peripheral nerve injury , 2008, Glia.

[7]  P. Siddall,et al.  Interferon-γ induced disruption of GABAergic inhibition in the spinal dorsal horn in vivo , 2007, PAIN®.

[8]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[9]  C. Woolf,et al.  The neuropathic pain triad: neurons, immune cells and glia , 2007, Nature Neuroscience.

[10]  Yi Dai,et al.  Roles of extracellular signal‐regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain , 2007, Journal of Neurochemistry.

[11]  Clifford J. Woolf,et al.  Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity , 2007, The Journal of Neuroscience.

[12]  I. Decosterd,et al.  Do glial cells control pain? , 2007, Neuron glia biology.

[13]  Sylvie Faucher,et al.  Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons , 2007, The Journal of Neuroscience.

[14]  S. McMahon,et al.  Role of spinal microglia in rat models of peripheral nerve injury and inflammation , 2007, European journal of pain.

[15]  Y. de Koninck,et al.  Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain , 2007, Molecular pain.

[16]  P. Siddall,et al.  Interferon-gamma induced disruption of GABAergic inhibition in the spinal dorsal horn in vivo. , 2007, Pain.

[17]  David S. Park,et al.  Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  W. Gan,et al.  The P2Y12 receptor regulates microglial activation by extracellular nucleotides , 2006, Nature Neuroscience.

[19]  H. Kettenmann,et al.  Purinergic signaling and microglia , 2006, Pflügers Archiv.

[20]  S. Koizumi,et al.  Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia , 2006, Glia.

[21]  J. Ando,et al.  Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice , 2006, Nature Medicine.

[22]  Ralf Baron,et al.  Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.

[23]  Kazuhide Inoue The function of microglia through purinergic receptors: neuropathic pain and cytokine release. , 2006, Pharmacology & therapeutics.

[24]  P. Siddall,et al.  Increased responsiveness of rat dorsal horn neurons in vivo following prolonged intrathecal exposure to interferon-γ , 2005, Neuroscience.

[25]  C. Gravel,et al.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.

[26]  V. Kapur,et al.  Transcriptional response of human microglial cells to interferon-γ , 2005, Genes and Immunity.

[27]  S. McMahon,et al.  Role of the Immune system in chronic pain , 2005, Nature Reviews Neuroscience.

[28]  J. Deleo,et al.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[30]  C. Hooper,et al.  Pure albumin is a potent trigger of calcium signalling and proliferation in microglia but not macrophages or astrocytes , 2005, Journal of neurochemistry.

[31]  M. Tsuda,et al.  Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia , 2005, Trends in Neurosciences.

[32]  Michael W. Salter,et al.  Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.

[33]  S. Koizumi,et al.  Activation of p38 mitogen‐activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury , 2004, Glia.

[34]  Kazuhide Inoue,et al.  Selective expression of Gi/o‐coupled ATP receptor P2Y12 in microglia in rat brain , 2003, Glia.

[35]  R. Hill,et al.  Interferon-γ induces characteristics of central sensitization in spinal dorsal horn neurons in vitro , 2003, Pain.

[36]  S. Koizumi,et al.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.

[37]  J. Deleo,et al.  Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[38]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[39]  K. Moore,et al.  A CD36-initiated Signaling Cascade Mediates Inflammatory Effects of β-Amyloid* , 2002, The Journal of Biological Chemistry.

[40]  C. Woolf,et al.  Can we conquer pain? , 2002, Nature Neuroscience.

[41]  K. Moore,et al.  A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. , 2002, The Journal of biological chemistry.

[42]  Steven F. Maier,et al.  Glial activation: a driving force for pathological pain , 2001, Trends in Neurosciences.

[43]  W. Seeger,et al.  Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[44]  M. Mullan,et al.  CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK Pathway* , 2000, The Journal of Biological Chemistry.

[45]  C. Woolf,et al.  Neuronal plasticity: increasing the gain in pain. , 2000, Science.

[46]  Georg W. Kreutzberg,et al.  Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function , 1999, Brain Research Reviews.

[47]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[48]  G. Landreth,et al.  Identification of Microglial Signal Transduction Pathways Mediating a Neurotoxic Response to Amyloidogenic Fragments of β-Amyloid and Prion Proteins , 1999, The Journal of Neuroscience.

[49]  B. Robertson,et al.  Interferon‐γ receptors in nociceptive pathways: role in neuropathic pain‐related behaviour , 1997 .

[50]  B. Robertson,et al.  Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-related behaviour. , 1997, Neuroreport.

[51]  M Aguet,et al.  The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.

[52]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.

[53]  T. Yamamoto,et al.  Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. , 1995, Immunity.

[54]  S. Ishiura,et al.  Identification of Elastase as a Secretory Protease from Cultured Rat Microglia , 1992, Journal of neurochemistry.